These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21762992)

  • 41. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
    Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
    Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies.
    Hovanesian JA; Sheppard JD; Trattler WB; Gayton JL; Malhotra RP; Schaaf DT; Ng E; Dunn SH
    J Cataract Refract Surg; 2015 Oct; 41(10):2060-8. PubMed ID: 26703280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
    Chen S; Jiang Y; Yu C; Li Y
    Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of food on bromfenac, naproxen sodium, and acetaminophen in postoperative pain after orthopedic surgery.
    Forbes JA; Sandberg RA; Bood-Björklund L
    Pharmacotherapy; 1998; 18(3):492-503. PubMed ID: 9620100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
    Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
    J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
    Bucci FA; Waterbury LD
    J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery.
    Tyson SL; Bafna S; Gira JP; Goldberg DF; Jones JJ; Jones MP; Kim JK; Martel JM; Nordlund ML; Piovanetti-Perez IK; Singh IP; Metzinger JL; Mulani D; Sane S; Talamo JH; Goldstein MH;
    J Cataract Refract Surg; 2019 Feb; 45(2):204-212. PubMed ID: 30367938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loteprednol etabonate ophthalmic gel 0.5% following cataract surgery: integrated analysis of two clinical studies.
    Rajpal RK; Fong R; Comstock TL
    Adv Ther; 2013 Oct; 30(10):907-23. PubMed ID: 24136301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
    Mukai K; Matsushima H; Gotoh N; Aose M; Satoshi W; Wataru T; Matsui E; Nagata M; Senoo T
    J Cataract Refract Surg; 2009 Sep; 35(9):1614-8. PubMed ID: 19683162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
    Wang C; Cao Y; Chen X; Cai M; Huang W
    Medicine (Baltimore); 2020 Dec; 99(49):e23131. PubMed ID: 33285687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
    Wentz SM; Price F; Harris A; Siesky B; Ciulla T
    Expert Opin Pharmacother; 2019 Oct; 20(14):1703-1709. PubMed ID: 31343372
    [No Abstract]   [Full Text] [Related]  

  • 54. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ; Dolan BJ
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery.
    Raizman MB; Donnenfeld ED; Weinstein AJ
    Curr Med Res Opin; 2007 Oct; 23(10):2325-31. PubMed ID: 17697456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED; Perry HD; Wittpenn JR; Solomon R; Nattis A; Chou T
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery.
    Boström AA; Forbes JA; Adolfsson C; Beaver WT; Bell WE
    Pharmacotherapy; 1994; 14(3):305-13. PubMed ID: 7937271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.